Quick Answer
Outset Medical, Inc. reported Common Stock Shares Outstanding of 18.17 million shares for the year ending 2025.
- Outset Medical, Inc. showed an increase of +414.7% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Outset Medical, Inc.'s annual report (Form 10-K), filed with the SEC on February 13, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2020: 42.70 million shares | Q1 2021: 42.89 million shares | Q2 2021: 46.23 million shares | Q3 2021: 47.02 million shares | Q1 2022: 47.71 million shares | Q2 2022: 48.00 million shares | Q3 2022: 48.30 million shares | Q1 2023: 49.22 million shares | Q2 2023: 49.63 million shares | Q3 2023: 50.17 million shares | Q1 2024: 51.70 million shares | Q2 2024: 52.08 million shares | Q3 2024: 52.54 million shares | Q1 2025: 17.72 million shares | Q2 2025: 17.77 million shares | Q3 2025: 17.81 million shares.
- Over the full 7 years of available data (2019 to 2025), Outset Medical, Inc.'s Common Stock Shares Outstanding has grown by 1,870.6%.
- Historical annual values: Fiscal year 2025: 18.17 million shares | Fiscal year 2024: 3.53 million shares | Fiscal year 2023: 50.32 million shares | Fiscal year 2022: 48.47 million shares | Fiscal year 2021: 47.24 million shares | Fiscal year 2020: 42.72 million shares | Fiscal year 2019: 922,000 shares.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: